Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy.
The present study was conducted to assess the use of coenzyme Q10 in the treatment of heart muscle disease (cardiomyopathy). This four-year study included 137 patients with cardiomyopathy who were given 100 mg of CoQ10 per day. After 2-3 months, ejection fraction (percentage of blood that is ejected from the heart with each contraction) increased to 41.6% and maintained between 43.1% and 49.7% for up to 36 months. The percentage of patients who lived at least 5 years after their diagnosis was 75% in the CoQ10 group, compared to only 25% in the control group that received conventional treatment. The authors concluded that CoQ10 is a promising supportive therapy for cardiomyopathy. More details can be found in the study.
The heart is the “motor” of our body, contracting about 80,000 times a day to pump the blood through our circulatory system. It is the mechanically the most active organ of our body. The actual “work” is performed by billions of muscle cells that contract at the same time to form the heartbeat. And just like in a car, the biological motor “heart” needs energy to function properly. Micronutrients are the most important carriers of biological energy for an optimum contraction of the heart muscle cells. A long-term dietary deficiency of micronutrients leads to an insufficient contraction of the heart muscle cells, to a suboptimal pumping function of the heart and eventually to heart failure (cardiomyopathy). Typical heart failure symptoms include shortness of breath, edema and chronic fatigue, making everyday activities such as house cleaning, walking or going to the supermarket very difficult.
Langsjoen PH, Folkers K, Lyson K, Muratsu K, Lyson T, Langsjoen P. Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy. Int J Tissue React. 1990;12(3):163-8.